相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biodistribution and Uptake of 3′-Deoxy-3′-Fluorothymidine in ENT1-Knockout Mice and in an ENT1-Knockdown Tumor Model
Robert J. Paproski et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Measuring Tumor Cell Proliferation with F-18-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study
Jinbo Yue et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Kinetics of 3′-Deoxy-3′-18F-Fluorothymidine During Treatment Monitoring of Recurrent High-Grade Glioma
Christiaan Schiepers et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
David A. Plotnik et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Esther G. C. Troost et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
Christina Pfannenberg et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Circulating Tumor M2 Pyruvate Kinase and Thymidine Kinase 1 Are Potential Predictors for Disease Recurrence in Renal Cell Carcinoma After Nephrectomy
Benjamin Nisman et al.
UROLOGY (2010)
Detection of sentinel lymph nodes after hysteroscopic peritumoral injection of Tc-99m-Nanocolloid in grade 1 endometrial carcinoma
Helmut Dittmann et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas
Matthias R. Benz et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
IMAGING CELLULAR PROLIFERATION DURING CHEMO-RADIOTHERAPY: A PILOT STUDY OF SERIAL 18F-FLT POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IMAGING FOR NON-SMALL-CELL LUNG CANCER
Sarah Everitt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Changes in tumor metabolism as readout for mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma
Liu Hua Wei et al.
CLINICAL CANCER RESEARCH (2008)
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine
Andreas K. Buck et al.
CLINICAL CANCER RESEARCH (2008)
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas
Vladimir Evilevitch et al.
CLINICAL CANCER RESEARCH (2008)
[18F] Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
Hee-Jung Sohn et al.
CLINICAL CANCER RESEARCH (2008)
Imaging of cell proliferation: Status and prospects
James R. Bading et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas:: Interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors
Matthias R. Benz et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography:: A pilot study
Wei Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer
Yuka Yamamoto et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
Laura Kenny et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Early response assessment using 3′-Deoxy-3′-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma
Ken Herrmann et al.
CLINICAL CANCER RESEARCH (2007)
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET
Bernd Kasper et al.
LEUKEMIA & LYMPHOMA (2007)
PET imaging with [F-18]3 '-deoxy-3 '-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer
Hinrich A. Wieder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Early detection of chemoradioresponse in esophageal carcinoma by 3′-deoxy-3′-3H-fluorothymidine using preclinical tumor models
Smith Apisarnthanarax et al.
CLINICAL CANCER RESEARCH (2006)
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography
CS Yap et al.
CHEST (2006)
Quantifying the effect of IV contrast media on integrated PET/CT: Clinical evaluation.
O Mawlawi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Usefulness of 3 '-[F-18]fluoro-3 '-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy
BS Pio et al.
MOLECULAR IMAGING AND BIOLOGY (2006)
Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging:: Evaluation of analytical methods.
LM Kenny et al.
CANCER RESEARCH (2005)
Detection and grading of soft tissue sarcomas of the extremities with 18F-3′-fluoro-3′-deoxy-L-thymidine
DCP Cobben et al.
CLINICAL CANCER RESEARCH (2004)
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl) adenine
YP Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas
FC Eilber et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Investigation on cell proliferation with a new antibody against thymidine kinase 1
NN Wang et al.
ANALYTICAL CELLULAR PATHOLOGY (2001)
分享论文
